Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

Autor: Anna Baiges, Eira Cerda, Caroline Amicone, Luis Téllez, Edilmar Alvarado-Tapias, Angela Puente, Jose Ignacio Fortea, Elba Llop, Filipa Rocha, Lara Orts, Oliva Ros-Fargas, Pamela Vizcarra, Kamal Zekrini, Ould Amara Lounes, Ghiles Touati, Natalia Jiménez-Esquivel, Maria Jose Serrano, Angels Falgà, Marta Magaz, Pol Olivas, Fabian Betancourt, Valeria Perez-Campuzano, Fanny Turon, Audrey Payancé, Odile Goria, Pierre-Emmanuel Rautou, Virginia Hernández-Gea, Candid Villanueva, Agustin Albillos, Aurélie Plessier, Juan-Carlos García-Pagán

Publikováno v: Clinical Gastroenterology and Hepatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de la UB
Universidad de Barcelona

Background & Aims: Vascular liver diseases (VLDs) are represented mainly by portosinusoidal vascular disease (PSVD), noncirrhotic splanchnic vein thrombosis (SVT), and Budd Chiari syndrome (BCS). It is unknown whether patients with VLDs constitute a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a386c0e30bbd9eb492a1f8465506e443
https://doi.org/10.1016/j.cgh.2021.12.032